BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3950676)

  • 1. Rhabdomyosarcoma: the Stanford experience using a TNM staging system.
    Pedrick TJ; Donaldson SS; Cox RS
    J Clin Oncol; 1986 Mar; 4(3):370-8. PubMed ID: 3950676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.
    Lawrence W; Anderson JR; Gehan EA; Maurer H
    Cancer; 1997 Sep; 80(6):1165-70. PubMed ID: 9305719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
    Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
    J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 5. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma.
    Mandell L; Ghavimi F; LaQuaglia M; Exelby P
    Med Pediatr Oncol; 1990; 18(6):466-71. PubMed ID: 2233517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in children with rhabdomyosarcoma.
    Gehan EA; Glover FN; Maurer HM; Sutow WW; Hays DM; Lawrence W; Newton WA; Soule EH
    Natl Cancer Inst Monogr; 1981 Apr; (56):83-92. PubMed ID: 7029299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
    Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
    J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE; Spronk P; van Rosmalen J; Wijnen MH; Heij HA; van Baren R; Merks JH; van Noesel MM; Wijnen RM
    J Pediatr Surg; 2014 Mar; 49(3):416-9. PubMed ID: 24650468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence treatment decisions in childhood rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Group of the Children's Cancer Group, the Pediatric Oncology Group, and the Intergroup Rhabdomyosarcoma Study Group Statistical Center.
    Donaldson SS; Anderson J
    Radiology; 1997 Apr; 203(1):17-22. PubMed ID: 9122388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of rhabdomyosarcoma: experience of the Intergroup Rhabdomyosarcoma Study, 1972-78.
    Gaiger AM; Soule EH; Newton WA
    Natl Cancer Inst Monogr; 1981 Apr; (56):19-27. PubMed ID: 7029289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II).
    Lawrence W; Gehan EA; Hays DM; Beltangady M; Maurer HM
    J Clin Oncol; 1987 Jan; 5(1):46-54. PubMed ID: 3543238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in childhood rhabdomyosarcoma of the extremity.
    Ghavimi F; Mandell LR; Heller G; Hajdu SI; Exelby P
    Cancer; 1989 Dec; 64(11):2233-7. PubMed ID: 2804912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
    Rogers T; Minard-Colin V; Cozic N; Jenney M; Merks JHM; Gallego S; Devalck C; Gaze MN; Kelsey A; Oberlin O; Stevens M; Spicer RD; Bergeron C; Martelli H
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28205365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM; Anderson JR; Meza JL; Fryer C; Raney RB; Ruymann FB; Breneman J; Qualman SJ; Wiener E; Wharam M; Lobe T; Webber B; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Jun; 19(12):3091-102. PubMed ID: 11408506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.